Emerging evidence suggests that these olfactory impairments may predict the onset of AD, amnestic mild cognitive impairment (aMCI), and the presence of amyloid-β (Aβ) and tau pathology in cognitively normal adults. This evidence concerns the gene MAPT and Alzheimer disease.